Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 31-40 of 134

Page
per page
  1. β-acetyl-Boswellic Acid
    C4123 β-acetyl-Boswellic Acid
    Summary: non-reducing inhibitor of 5-lipoxygenase (5-LO)
      ≤5 mg/mL
  2. N-3-oxo-dodecanoyl-L-Homoserine lactone
    C4107 N-3-oxo-dodecanoyl-L-Homoserine lactone
    Summary: NF-κB and AP-2 activator
      ≥32.2 mg/mL
  3. Bradykinin (acetate)
    C4126 Bradykinin (acetate)
    Summary: inflammatory mediator
      ≥113 mg/mL
  4. PPM-18
    C4074 PPM-18
    Summary: NF-κB inhibitor
      ≥27.7 mg/mL
  5. (S)-Lisofylline
    C4161 (S)-Lisofylline
    Summary: inactive optical enantiomer of (R)-LSF, an anti-inflammatory agent
      ≤15 mg/mL
  6. (R)-Lisofylline
    C4158 (R)-Lisofylline
    Summary: anti-inflammatory agent
      ≤25 mg/mL
  7. (±)-Lisofylline
    C4298 (±)-Lisofylline
    Summary: anti-inflammatory agent
      ≤2 mg/mL
  8. ATB-343
    C4596 ATB-343
    Summary: hybrid molecule of an H2S donor and the NSAID indomethacin
      ≤10 mg/mL
  9. Isoprinosine
    C4417 Isoprinosine
    Summary: immunomodulatory effects
      insoluble in EtOH; ≥58.7 mg/mL
  10. ML351
    C4277 ML351
    Summary: human reticulocyte 15-LO-1 inhibitor
      ≤5 mg/mL

Items 31-40 of 134

Page
per page